Better Buy: Pfizer vs. Apple

We've collected the most popular companies amongst readers and put them head-to-head in a good old-fashioned challenge we're calling The Motley Fool Better Buy Tournament.

Mar 18, 2014 at 4:35PM

In today's ­first round match-up of The Motley Fool Better-Buy Tournament, Pfizer squares off against Apple in a battle to determine which stock is the better buy now. The 64-company tournament pits two Motley Fool analysts against each as they make the case for their stocks with the winner determined by you, the readers.

In response to losing cash cow Lipitor, Pfizer (NYSE:PFE) reimagined itself as a focused drug development company, selling off its nutrition business and spinning out its animal health division. Pfizer has 5 drugs with over $2 billion in 2013 sales each; and Pfizer management is focused on shareholder value -- increasing the dividend while decreasing share count via buybacks. Pfizer's 3.2% dividend has a low payout ratio of only 30% and the company is flush with cash making increases likely in the future. Finally, drugs like Xeljanz and Prevnar have a strong growth trajectory while developmental assets like palbociclib in breast cancer may be the next great Pfizer blockbuster, according to Motley Fool analyst David Williamson.

Motley Fool tech and telecom analyst Andrew Tonner makes the case for Apple (NASDAQ:AAPL) to advance to the next round because of its intriguing mix of value and growth potential. As the world's largest publicly traded company, it's grown increasingly difficult for Apple to maintain its historically high growth rates, much to its investors' dismay. However, the tide could be ready to turn for Apple as the company should introduce at least one new product this year, which could reenergize this tech giant's growth in the months, and even years, to come.

Watch these analysts square off in the video below and then vote for a winner. Then check out the other companies in the Motley Fool Better-Buy Bracket

This year's winning stock?
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Cast your vote in the poll below the video!

Andrew Tonner owns shares of Apple. David Williamson owns shares of Apple and Pfizer. The Motley Fool recommends Apple. The Motley Fool owns shares of Apple. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information

Compare Brokers